Do the potential benefits outweigh the risks? An update on the use of ziconotide in clinical practice

@article{Bckryd2018DoTP,
  title={Do the potential benefits outweigh the risks? An update on the use of ziconotide in clinical practice},
  author={E. B{\"a}ckryd},
  journal={European Journal of Pain},
  year={2018},
  volume={22}
}
  • E. Bäckryd
  • Published 2018
  • Medicine
  • European Journal of Pain
    • Ziconotide is a selective and potent blocker of N‐type voltage‐gated calcium channels. It was approved by the Food and Drug Administration in 2004 and by the European Medicines Agency in 2005 for the treatment of severe chronic pain in patients needing intrathecal analgesia (ITA). The aim of this paper is to provide a practitioner‐oriented, educational, narrative, up‐to‐date review on the use of ziconotide in clinical pain medicine. Of special concern regarding safety is the partial incongruity… CONTINUE READING
    View on Wiley
    liu.diva-portal.org
    Top 3 of 9 Citations
    Membrane Stabilizer Medications in the Treatment of Chronic Neuropathic Pain: a Comprehensive Review
    Omar Viswanath, Ivan Urits, … A. KayeCurrent Pain and Headache Reports2019
    3
    Animal toxins — Nature’s evolutionary-refined toolkit for basic research and drug discovery
    V. Herzig, B. Cristofori-Armstrong, … G. KingBiochemical Pharmacology2020
    8
    Intrathecal therapy for pain in cancer patients
    D. DupoironCurrent opinion in supportive and palliative care2019
    2

    Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    9 Citations
    Citation Type

    Citation Type

    Membrane Stabilizer Medications in the Treatment of Chronic Neuropathic Pain: a Comprehensive Review
    • 3
    Animal toxins — Nature’s evolutionary-refined toolkit for basic research and drug discovery
    • 8
    Intrathecal therapy for pain in cancer patients
    • 2
    Ziconotide for spinal cord injury‐related pain
    • 3
    Managing Chronic Non-Malignant Pain in the Elderly: Intrathecal Therapy
    • 1
    • PDF
    Pharmakologie der Nichtopioidanalgetika
    • 1
    Virtual insights on G protein inhibition and ion channel block – a computer-based study
    Neurochirurgie et douleurs cancéreuses – état des lieux et perspectives
    Where We Come From and Are We Aware of Where We Are Going To

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 103 REFERENCES
    Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
    • 1,439
    • PDF
    Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.
    • 520
    • PDF
    Ziconotide for treatment of severe chronic pain
    • 231
    • Highly Influential
    • PDF
    Ziconotide: neuronal calcium channel blocker for treating severe chronic pain.
    • 420
    Ziconotide: a clinical update and pharmacologic review
    • 86
    A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.
    • 231
    • Highly Influential
    Intrathecal Ziconotide for Severe Chronic Pain: Safety and Tolerability Results of an Open-Label, Long-Term Trial
    • 94
    Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain
    • 65
    • Highly Influential
    • PDF
    Ziconotide, A New N‐Type Calcium Channel Blocker, Administered Intrathecally for Acute Postoperative Pain
    • 123
    Ziconotide adverse events in patients with cancer pain: a multicenter observational study of a slow titration, multidrug protocol.
    • 60
    • PDF